Barclays PLC Ionis Pharmaceuticals Inc Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$40.06 - $51.86 $4.01 Million - $5.19 Million	100,000 New	100,000 $4.01 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $1.26 Million - $1.61 Million	-30,000 Reduced 54.55%	25,000 $1.08 Million
Q4 2023 Feb 15, 2024	BUY	$43.39 - $51.63 $2.39 Million - $2.84 Million	55,000 New	55,000 $2.78 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $175,565 - $232,915	-3,700 Reduced 35.58%	6,700 $318,000
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $777,710 - $1.01 Million	-16,600 Reduced 61.48%	10,400 $613,000
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $3.71 Million - $5.65 Million	-89,100 Reduced 76.74%	27,000 $1.28 Million
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $673,125 - $815,875	12,500 Added 12.07%	116,100 $7.01 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $4.67 Million - $5.71 Million	79,100 Added 322.86%	103,600 $6.21 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2.61 Million - $3.62 Million	-42,000 Reduced 63.16%	24,500 $1.58 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $1.15 Million - $1.77 Million	-21,800 Reduced 24.69%	66,500 $5.4 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $1.95 Million - $2.67 Million	-44,900 Reduced 33.71%	88,300 $4.77 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1.67 Million - $2.09 Million	39,000 Added 41.4%	133,200 $6.87 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $1.61 Million - $2.01 Million	-39,700 Reduced 29.65%	94,200 $3.93 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $877,192 - $1.1 Million	19,900 Added 17.46%	133,900 $5.9 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $528,150 - $676,095	-10,500 Reduced 8.43%	114,000 $5.73 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $5.67 Million - $7.42 Million	124,500	124,500 $6.31 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$518 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$377 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$319 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$288 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account